Comparative efficacy of chronic lymphocytic leukemia treatment with or without rituximab
Background. Monoclonal antibodies are modern drugs for the treatment of chronic lymphocytic leukemia.The objective is a comparative study of the monoclonal antibody rituximab efficacy when added to cyclophosphamide + fludarabine (RFC versus FC regimen) in the treatment of chronic lymphocytic leukemi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-12-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/379 |